Innoviva Inc. (INVA) |
|
14.54 0.04 (0.28%)
|
05-22 16:00 |
|
Open: |
14.45 |
Pre. Close: |
14.5 |
|
High:
|
14.725 |
Low:
|
14.34 |
|
Volume:
|
659,596 |
Market Cap:
|
1472M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.744 - 14.8 |
14.8 - 14.866 |
|
Low:
|
14.186 - 14.247 |
14.247 - 14.317 |
|
Close:
|
14.427 - 14.524 |
14.524 - 14.637 |
|
|
|
Technical analysis |
as of: 2019-05-22 4:24:53 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 17.84 One year: 20.83 |
| Support: |
Support1: 13.91 Support2: 13.07 |
| Resistance: |
Resistance1: 15.27 Resistance2: 17.84 |
| Pivot: |
14.63 |
| Moving Average: |
MA(5): 14.53  MA(20): 14.43
MA(100): 15.47 MA(250): 15.27 |
| MACD: |
MACD(12,26): 0.11 Signal(9): 0.12 |
| Stochastic oscillator: |
%K(14,3): 47.00 %D(3): 50.28 |
| RSI: |
RSI(14): 52.78 |
| 52-week: |
High: 20.54 Low: 13.07 Change(%): 3.1 |
| Average Vol(K): |
3-Month: 93634 10-Days: 135091 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.INVA has closed above bottom band by 39.4%. Bollinger Bands are 66% narrower than normal. The narrow width of the bands suggests low volatility as compared to INVA's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 22 May 2019 13:10:41 Z
5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon
Wed, 15 May 2019 16:13:30 Z
New Strong Buy Stocks for May 15th
Wed, 15 May 2019 16:11:52 Z
Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy?
Fri, 26 Apr 2019 17:10:16 Z
Commit To Buy Innoviva At $10, Earn 9.9% Annualized Using Options
Thu, 18 Apr 2019 17:08:46 Z
Innoviva Becomes Oversold (INVA)
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
101.26 |
| Shares Float (M) |
94.31 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
3.590 |
|
EPS Est. Current Year
|
1.130 |
|
EPS Est. Next Year
|
1.930 |
|
EPS Est. Next Quarter
|
0.480 |
|
Forward EPS
|
2.190 |
|
Book Value (p.s.)
|
7.970 |
|
PEG Ratio
|
0.49 |
|
Profit Margin
|
|
|
Operating Margin
|
94.96 |
|
Return on Assets (ttm)
|
94.8 |
|
Return on Equity (ttm)
|
-12715.0 |
|
Qtrly Rev. Growth
|
5.4 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
14.20 |
|
Operating Cash Flow (M)
|
250.27 |
|
Levered Free Cash Flow (M)
|
163.54 |
Stock Valuations |
|
P/E
|
4.05 |
|
P/E Growth Ratio
|
|
|
P/BV
|
1.82 |
|
P/S
|
564107392.00 |
|
P/CF
|
5.88 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2015-09-30 |
|
Ex-Dividend Date
|
2015-09-08 |
|
Forward Dividend
|
|
|
Last Split Date
|
2014-06-03 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
